Paul McGinley Golfs with Trump at Scottish Course Opening
Amgen takes the Green Flag as Irish Open Sponsor,But Trade Tensions Loom
Table of Contents
The prestigious Amgen Irish Open is set to tee off at The K Club in September,with American pharmaceutical giant Amgen now firmly in the sponsor’s seat. This move follows Amgen’s acquisition of Horizon Therapeutics, the company that initially secured a sponsorship deal for the event from 2022 through 2027.
A New Era for the Irish Open
the Clare venue is reportedly on track to host next year’s amgen Irish Open, marking a significant chapter for the renowned golf tournament. US pharmaceutical leaders Horizon Therapeutics stepped in as sponsors in 2022,establishing a commitment to back the event until 2027. However, a major shift occurred in 2023 when Horizon was acquired by Amgen, a multinational biopharmaceutical company with a significant presence in Ireland, including major manufacturing plants. This transition has seamlessly placed Amgen as the new title sponsor for the Irish Open.
Golfing Greats Align with Amgen
The partnership extends beyond the corporate realm, with several prominent Irish golfers serving as ambassadors for Amgen. Pádraig Harrington, shane Lowry, Séamus Power, and Brendan Lawlor are all lending their names and influence to the brand, highlighting the strong connection between the sport and the pharmaceutical industry in Ireland.
While the sponsorship brings a new wave of excitement and investment to the Irish Open, Amgen, like many multinational corporations, faces potential headwinds from global trade dynamics. specifically, the looming threat of President Trump’s trade war could significantly impact Amgen’s operations.
As reported by the Irish Independent, there’s a palpable sense of uncertainty within both the Irish government and the European Union regarding the scope of a baseline 15% tariff, which is set to be implemented this Friday following a US trade deal. The critical question remains whether pharmaceuticals, a vital sector for the Irish economy, will be included in this 15% bracket or face even higher levies.This ambiguity could have far-reaching consequences for companies like Amgen, influencing their investment strategies and operational stability in Ireland. The coming weeks will be crucial in determining the impact of these trade policies on key industries and major sporting events alike.